Angel One Reports April 2026 Business Update: Client Base Hi...
Source: scanx.trade
ICICI Prudential Life Insurance Company Limited has allotted 97,746 equity shares of face value ₹10 each on May 5, 2026, under its employee stock option schemes. The allotment was approved by the Managing Director & CEO of the company at 1:03 p.m. IST, pursuant to authority delegated by the Board of Directors at its meeting held on January 22, 2019.
Scheme-wise Allotment Breakdown
The total allotment of 97,746 equity shares was distributed across two distinct employee stock schemes. The following table provides a detailed breakdown of the allotment:
Scheme: Shares Allotted Employees Stock Option Scheme (2005): 95,650 equity shares Employees Stock Unit Scheme (2023): 2,096 equity shares Total Allotted: 97,746 equity shares
Allotment Details and Ranking
The newly allotted equity shares carry a face value of ₹10 each and shall rank pari-passu with the existing equity shares of the company. This means the allotted shares carry the same rights and entitlements as the currently outstanding equity shares of ICICI Prudential Life Insurance. The intimation of this allotment was formally communicated to both BSE Limited and the National Stock Exchange of India Limited on May 5, 2026, by Company Secretary Priya Nair (ACS 17769), in compliance with applicable listing requirements.
ICICI Prudential Life Insurance Company Limited has completed the allotment of equity shares under its Employee Stock Option and Stock Unit schemes, marking a continued commitment to its employee compensation strategy. The company informed stock exchanges about this corporate action through an official communication on May 5, 2026.
Share Allotment Details
The company allotted a total of 97,746 equity shares of face value ₹10 each on May 5, 2026, across two employee benefit schemes. The allotment specifics are outlined in the following table:
Parameter: Details Total Shares Allotted: 97,746 equity shares Face Value: ₹10 each Allotment Date: May 5, 2026 Approval Time: 1:03 p.m. IST
Scheme-Wise Breakdown
The allotment was distributed across two distinct employee benefit schemes. The scheme-wise breakdown is as follows:
Scheme: Shares Allotted Employees Stock Option Scheme (2005): 95,650 equity shares Employees Stock Unit Scheme (2023): 2,096 equity shares
Approval and Authorization
The allotment received approval from the Managing Director & CEO of the company on May 5, 2026. This approval was granted pursuant to the authority delegated by the Board of Directors at its meeting held on January 22, 2019. The delegation of authority allows the management to execute employee stock option allotments without requiring fresh board approval for each instance.
Share Rights and Regulatory Compliance
The newly allotted equity shares rank pari-passu with the existing equity shares of the company, ensuring that employees receiving these shares have the same voting rights, dividend entitlements, and other shareholder benefits as existing equity shareholders. The company fulfilled its disclosure obligations by informing both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) about this allotment. The communication was signed by Company Secretary Priya Nair and includes all necessary details required under regulatory guidelines for such corporate actions.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.
Source: scanx.trade
Source: The Economic Times
Source: Free Press Journal